{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:03:21Z","timestamp":1792839801090,"version":"4.5.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Known risk factors for new-onset atrial fibrillation\/flutter (NOAF) include thyrotoxicosis and subclinical hypothyroidism. While prior research has predominantly explored the link between thyrotoxicosis and NOAF, the presence of subclinical hypothyroidism among patients presenting with acute NOAF in the emergency department (ED) remains an underexplored area of inquiry. This study aimed to assess the prevalence of undiagnosed thyrotoxicosis and subclinical hypothyroidism in patients with acute NOAF diagnosed in the ED.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This registry-based cohort study was conducted in the ED at Vrinnevi Hospital in Sweden during the years 2018, 2020, and 2022, with a 1-year follow-up period. Patients \u226518 years diagnosed with NOAF in the ED, with no ongoing thyroid hormone substitution or previous documented thyroid abnormality within the past 2 years, were included. The primary outcome was the diagnosis of thyrotoxicosis or subclinical hypothyroidism either in the ED or during a 1-year follow-up period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>486 patients with NOAF were included in the study (43.6% females). 329 (67.7%) underwent thyroid function testing in the ED or by the end of the 1-year follow-up. In total, 16 (4.9%) patients presented with subclinical hypothyroidism while 4 (1.2%) patients presented with clinical or subclinical thyrotoxicosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This study found that subclinical hypothyroidism was more prevalent (4.9%) than thyrotoxicosis (1.2%) among patients presenting with acute NOAF. These findings contrast with previous research that has predominantly linked thyrotoxicosis with acute NOAF, suggesting the need for further studies including both subclinical hypothyroidism and thyrotoxicosis in patients with NOAF.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2024.1518297","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T06:14:00Z","timestamp":1736489640000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of abnormal thyroid hormone levels in acute new-onset atrial fibrillation"],"prefix":"10.3389","volume":"11","author":[{"given":"Jakob","family":"Hytting","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linus","family":"Bodestr\u00f6m Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Mallios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christofer","family":"Digerfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Waldemar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Wijkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Singull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Hubbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"i4482","DOI":"10.1136\/bmj.i4482","article-title":"Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis","volume":"354","author":"Odutayo","year":"2016","journal-title":"Br Med J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1161\/CIRCULATIONAHA.114.014343","article-title":"Mass screening for untreated atrial fibrillation the STROKESTOP study","volume":"131","author":"Svennberg","year":"2015","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham heart study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1001\/archinte.164.15.1675","article-title":"Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study","volume":"164","author":"Frost","year":"2004","journal-title":"Arch Intern Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/medicina58111513","article-title":"Incidence and determinants of spontaneous cardioversion of early onset symptomatic atrial fibrillation","volume":"58","author":"Mariani","year":"2022","journal-title":"Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4259183","article-title":"Thyrotoxic atrial fibrillation: factors associated with persistence and risk of ischemic stroke","volume":"2017","author":"Wong","year":"2017","journal-title":"J Thyroid Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"Taylor","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.eprac.2022.05.008","article-title":"Effects of thyroid dysfunction and the thyroid-stimulating hormone levels on the risk of atrial fibrillation: a systematic review and dose-response meta-analysis from cohort studies","volume":"28","author":"Huang","year":"2022","journal-title":"Endocr Pract"},{"key":"B11","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1067\/mhj.2001.119370","article-title":"Subclinical hyperthyroidism as a risk factor for atrial fibrillation","volume":"142","author":"Auer","year":"2001","journal-title":"Am Heart J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/BMJ.E7895","article-title":"The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study","author":"Selmer","year":"2012","journal-title":"Br Med J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"82N","DOI":"10.1016\/S0002-9149(98)00589-X","article-title":"The Canadian registry of atrial fibrillation: a noninterventional follow-up of patients after the first diagnosis of atrial fibrillation","volume":"82","author":"Kerr","year":"1998","journal-title":"Am J Cardiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1001\/archinte.1996.00440180083010","article-title":"How useful is thyroid function testing in patients with recent-onset atrial fibrillation?","volume":"156","author":"Krahn","year":"1996","journal-title":"Arch Intern Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/europace\/eux301","article-title":"Contemporary stroke prevention strategies in 11,096 European patients with atrial fibrillation: a report from the EURObservational research programme on atrial fibrillation (EORP-AF) long-term general registry","volume":"20","author":"Boriani","year":"2018","journal-title":"Europace"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e57893","DOI":"10.1371\/journal.pone.0057893","article-title":"New-onset atrial fibrillation is a predictor of subsequent hyperthyroidism: a nationwide cohort study","volume":"8","author":"Selmer","year":"2013","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0002-9149(79)90243-1","article-title":"Occult thyrotoxicosis: a correctable cause of \u201cidiopathic\u201d atrial fibrillation","volume":"44","author":"Forfar","year":"1979","journal-title":"Am J Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.ajem.2010.06.010","article-title":"Utility of routine thyroid-stimulating hormone determination in new-onset atrial fibrillation in the ED","volume":"29","author":"Buccelletti","year":"2011","journal-title":"Am J Emerg Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.21972","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human participants","year":"2024","journal-title":"JAMA"},{"key":"B21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.7861\/clinmedicine.13-3-282","article-title":"How to interpret thyroid function tests","volume":"13","author":"Levy","year":"2013","journal-title":"Clin Med (Lond)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1445-5994.1985.tb04036.x","article-title":"The diagnostic challenge of euthyroid hyperthyroxinemia","volume":"15","author":"Stockigt","year":"1985","journal-title":"Aust N Z J Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.beem.2013.10.003","article-title":"Pitfalls in the measurement and interpretation of thyroid function tests","volume":"27","author":"Koulouri","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0296413","article-title":"Subclinical thyroid dysfunction and the risk of incident atrial fibrillation: a systematic review and meta-analysis","volume":"19","author":"Singh","year":"2024","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1530\/EJE-11-0548","article-title":"Incidence of hyperthyroidism in Sweden","volume":"165","author":"Abraham-Nordling","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12020-020-02222-7","article-title":"Incidence and prevalence of hyperthyroidism: a population-based study in the piedmont region, Italy","volume":"69","author":"Caputo","year":"2020","journal-title":"Endocrine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1210\/clinem\/dgad448","article-title":"Higher risk of incident hyperthyroidism in patients with atrial fibrillation","volume":"109","author":"Huang","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1167","DOI":"10.1210\/clinem\/dgad623","article-title":"Incidence and determinants of spontaneous normalization of subclinical hypothyroidism in older adults","volume":"109","author":"Van Der Spoel","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1210\/jc.2011-3020","article-title":"Age-related changes in thyroid function: a longitudinal study of a community-based cohort","volume":"97","author":"Bremner","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000356507","article-title":"2013 ETA guideline: management of subclinical hypothyroidism","volume":"2","author":"Pearce","year":"2014","journal-title":"Eur Thyroid J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"l2006","DOI":"10.1136\/bmj.l2006","article-title":"Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline","volume":"365","author":"Bekkering","year":"2019","journal-title":"Br Med J"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2020.00001","article-title":"Levothyroxine for the treatment of subclinical hypothyroidism and cardiovascular disease","volume":"11","author":"Sue","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B33","volume-title":"Thyroid Disease: Assessment and Management","year":"2019"},{"key":"B34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4022\/jafib.710","article-title":"Subclinical hypothyroidism: an overlooked cause of atrial fibrillation?","volume":"5","author":"Kolettis","year":"2012","journal-title":"J Atr Fibrillation"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1518297\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T06:14:05Z","timestamp":1736489645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1518297\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":34,"alternative-id":["10.3389\/fcvm.2024.1518297"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1518297","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"article-number":"1518297"}}